Another study of SLC11A1/NRAMP1 (natural resistance-associated macrophage protein 1) in patients who used INH, PZA, RIF, EMB, kanamycin, and streptomycin showed that genetic variations in SLC11A1 may affect the incidence of MDR-TB (OR = 5.03 95% CI [1.24-20.62] p = 0.02 and OR = 5.03 CI95% [1.24-20.62] p = 0.02) and clinical features of pulmonary TB, which could be explained by a longer time to sputum culture conversion. The gene discussed is SLC11A1; the disease is tuberculosis.